Bunchman Welcome
Upcoming SlideShare
Loading in...5
×
 

Like this? Share it with your network

Share

Bunchman Welcome

on

  • 825 views

 

Statistics

Views

Total Views
825
Views on SlideShare
825
Embed Views
0

Actions

Likes
0
Downloads
3
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Bunchman Welcome Presentation Transcript

  • 1. Welcome
  • 2.  
  • 3. Dear Tim, as far as I know this is the first patient treated with CAVH in the world. We performed this treatment in Vicenza in 1984 and the patient survived. After that we published the first series of 4 newborns treated with CAVH (Kidney International 1986) . You made a great deal of progress since then and even more with this meeting. Best Wishes Claudio Ronco
  • 4. Time and Transition
    • 1984-Ronco’s KI paper
    • 1990-CAVH becomes more common
    • 1993-CVVH with adapted machinery
    • 1995-automated CVVH(D) machinery
    • 1997-ultrafiltration controllers with automated machinery
    • 1998-Acute Dialysis Quality Initiative (ADQI.net)
    • 1999-Thermic controls with automated machinery
  • 5. Time and Transition
    • 2000-1 st International Conference on Pediatric Continuous Renal Replacement Therapy
    • 2001-1 st FDA approved Bicarbonate Based Dialysate (Normocarb)
    • 2001-ppCRRT Registry establishment (Stu Goldstein)
    • 2001-Goldstein data on FO and outcome
    • 2002-Citrate anticoagulation
    • 2002-PCRRT 2
    • 2002-PEDCRRT list serve
  • 6. Time and Transition
    • Gambro releases Prismasate
    • 2003-DiCarlo data on early intervention in Bone Marrow Transplantation
    • 2004-Foland data on FO and outcome
    • 2004-Data emerging on Pharmacy Errors
    • 2004-PCRRT 3
    • 2005-KI paper from ppCRRT
    • 2006 PCRRT-Zurich
  • 7. DIALYSIS MODALITY Belsha et al., Pediatr Nephrol, 1995 Patients (%)
  • 8. Pediatric Choice of RRT # on RRT/yr Year of RRT
  • 9. Why has this become common?
    • Work in vascular access
    • Dedicated staff who is interested in these children
    • Patients continue to be sicker then historically
    • Automated machinery has made the care easier
    • Anticoagulation protocols have made it easier
  • 10. CRRT: Who does it?
    • Outside of NA wide country variation of whom is responsible for this therapy
    • Within NA
      • USA ~ 60% done by Nephrology but often determined by manpower
        • Adult Nephrologists = Adult Intensivists
        • Pediatric Nephrologists < Pediatric Intensivists
      • Canada ~ 50% done by Nephrology
  • 11. Who really does CRRT?
    • Nursing staff of the
    • Dialysis units- thank you
    • Critical Care units- thank you
    • Neonatal intensive Care units- thank you
  • 12. What is the purpose of this meeting?
    • To bring together those in the field who deal with any modality of MOSF with RRT who are willing to listen and learn, to talk and to exchange
    • There are no experts in this field!!
    • “If you quit learning then it is time to go home”
      • (actually he said get the hell out before you hurt someone!)
        • Robert Vernier MD (U of Mn, retired)
  • 13. Thank you
    • To those of you who helped make this meeting happen
      • Faculty
      • Carol Malone
        • Program and Meeting planner-USA
      • Katrin Burow
        • Program and Meeting planner-Europe
      • PCRRT Organizing committee
      • PCRRT Foundation, Inc
  • 14. Who are the faculty?
    • Oskar Baenziger, MD
      • University Children’s Hospital, Z ü rich, Switzerland
    • Klaus-Eugen Bonzel, MD
      • University Children’s Hospital, Essen, Germany
  • 15. Who are the faculty?
    • Patrick D. Brophy, MD, FRCPC
      • C.S. Mott Children’s Hospital at the University of Michigan, Ann Arbor, Michigan, USA
    • Timothy E. Bunchman, MD
      • DeVos Children’s Hospital, Grand Rapids, Michigan, USA
  • 16. Who are the faculty?
    • Ali Dodge-Khatami, MD, PhD
      • University Children’s Hospital, Z ü rich, Switzerland
    • Michel Fischbach, MD
      • H ô pital de Hautepierre, Strasbourg, France
  • 17. Who are the faculty?
    • Bernhard Frey, MD
      • University Children’s Hospital, Z ü rich, Switzerland
    • Andree V. Gardner
      • DeVos Children’s Hospital, Grand Rapids, Michigan, USA
  • 18. Who are the faculty?
    • John J. Gardner, RN
      • DeVos Children’s Hospital, Grand Rapids, Michigan, USA
    • Peter Gessler, MD
      • University Children’s Hospital, Z ü rich, Switzerland
  • 19. Who are the faculty?
    • Markus J. Kemper, MD
      • University Children’s Hospital Eppendorf, Hamburg, Germany
    • Ernst P. Leumann, MD
      • University Children’s Hospital, Z ü rich, Switzerland
  • 20. Who are the faculty?
    • Marco Maggiorini, MD
      • University Hospital, Z ü rich, Switzerland
    • Thomas J. Neuhaus, MD
      • University Children’s Hospital, Z ü rich, Switzerland
  • 21. Who are the faculty?
    • Ekkehard Ring, MD
      • Medical University Graz, Graz, Austria
  • 22. Thanks to our Supporters-1
    • Arrow International
    • Baxter Health Care
    • Dialysis Solution Inc
    • Edwards Life Sciences
    • Freseuius
    • Gambro Hospal
    • Janssen-Cilag
  • 23.
    • Novo Nordisk
    • Novartis
    • Pfizer
    • Roche
    • Vicor
    • Government of Zurich (city and county)
    • Swiss parents association of children with kidney disease
    Thanks to our Supporters-2
  • 24. Who are the Audience
    • 27 abstracts were submitted from 12 separate countries
    • 50% make up of Nursing
    • 45% physician
    • 5% pharmacist
  • 25. A few requests
    • Ask questions..
      • we all learn
    • Interact with others outside your program during the breaks, lunch
    • Visit the booths
      • learn what each machine, solution, and access can do for your program
  • 26. A few requests
    • Fill out your evaluation cards and hand them into the desk
      • CMEs and CEUs are available for those requesting
  • 27. Finally
    • Have fun and open your mind
    • This is a therapy that is still in development. The applications of these therapies are without boundaries
    • If Carol Malone, Katrin Burow, Thomas Neuhaus, Oskar Baenziger or I can help you in any way, please do not hesitate to ask.
  • 28. Quote that I live by
    • “the smartest one in the room is the child”